Issued Patents

• US11219677B2 - 1/11/2022 -Kwang Poo Chang, et al. - Immunotherapy of Canine Leishmaniasis
• US11116785B2 - 9/14/2021 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
• US10822325B2 - 11/3/2020 - Jun-Yong Choe, et al. - Human GLUT5 Specific Inhibitor Using Virtual Screening and in Vitro Transport Evaluation
•  US10787669B2 - 9/29/2020 - Michelle Hastings, et al. - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Disease
• US10729370 - 8/4/2020 - Lin Fang and Sai Yalla - Mobile Sensor System and Methods for Use
• US10721993 - 7/28/2020 - Noah Rosenblatt, Ryan Crews, et al. - Intelligent Offloading Insole Device
• US10544417B2 - 1/28/2020 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
• US10525076B2 - 1/24/2020 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
• US10472634B2 - 11/12/2019 - Michelle Hastings, et al. - Antisense Compounds Targeting Apolipoprotein E Receptor 2 (Alzheimer)
• US10370667B2 - 8/6/2019 - Michelle Hastings, et al. - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Desease
• US10070648 - 9/11/2018 - Kwang Poo Chang - Photodynamic Insecticides
• US10028906B2 - 7/24/2018 - Bruce Riser - Method and Kit for Treating a Solid Tumor and Associated Desmoplasia
• US10351608B2 - 7/16/2019 -  Bruce Riser - CCN3 and CNN3 Peptides and Analogs Thereof for Therapeutic Use
• US10011578B2 - 7/3/2018 - Grace Stutzmann - Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release  
• US9970056 - 5/15/2018 - Judith Potashkin - Methods and Kits for Diagnosing, Prognosing and Monitoring Parkinsons Disease
• US9839389 - 12/12/2017 - Karen Stevens - Foot-Strength Test Device and Methods for Use
• US9840709 - 12/12/2017 -  Michelle Hastings - Antisense Compounds Targeting Genes Associated With Cystic Fibrosis
• US9840710 - 12/12/2017 -  Michelle Hastings - Antisense Compounds Targeting Leucine-RICH Repeat Kinase 2 (LRRL2) for the Treatment of Parkinson Desease
• US9827478B1 - 11/28/2017 -  Bijan Najafi, et al. - Providing Visual Motion Feedback Based on Sensor Data
• US9753042 B2 - 9/5/2017 - Kenneth Beaman - Kits for determining male fertility by measuring levels of a2V-ATPase, G-CSF, MIP 1 alpha, MCP-1, and methods and kits for improving reproductive outcomes in artificial insemination procedures
• US9725429 B2 - 8/8/2017 - Grace Stutzmann - Furan-based Compounds for Stabilizing Ryanodine Receptors from Aberrant Levels of Calcium Release and Method for Treating Alzheimer's Disease with these Compounds
• US9556434 - 1/31/2017 - Michelle Hastings - Antisense oligonucleotides that target a cryptic splice site in Ush1c as a therapeutic for usher syndrome
• US9532961 - 1/3/2017 - Darryl Peterson - A method and kit for administering gamma-glutamyl-D-cysteine for the prevention of reperfusion injury following ischemic stroke  
• US9353371 - 5/31/2016 - Michelle Hastings, et al. - Antisense Compounds Targeting Genes Associated with usher syndrome
• US9327017 - 5/3/2016 - Kwang-Poo Chang, Sujoy Dutta - Leishmania-based carrier for vaccine delivery
• US9114112 - 8/25/2015 - Bruce Riser - CNN3 and CNN3 peptides and analogs thereof for therapeutic use
• US9102645 - 8/11/2015 - Grace Stutzman - Compounds for stabilizing ryanodine receptors from aberrant levels of calcium release
• US8979665B1 - 3/17/2015 - Bijan Najafi, et al. - Providing Motion Feedback Based on User Center of Mass
• US8841436 - 9/23/2014 -Judith Potashkin, et al. - Screening, diagnosing, treating and prognosis of pathophysiologic status by RNA regulation
• US8772468 - 7/8/2014 - Judith Potashkin - Splice variant specific messenger RNA transcripts as biomarkers of Parkinson's disease
• US8753275B2 - 6/17/2014 - Bijan Najafi, et al. - Intelligent Device to Monitor And Remind Patients With Footwear, Walking Aids, Braces, Or Orthotics
• US8648053 - 2/11/2014 - Michelle Hastings - Antisense oligonucleotides that target a cryptic splice site in USH1C as a therapeutic for usher syndrome
• US8518886 - 8/27/2013 - Darryl Peterson - Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke
• US8518395 - 8/27/2013 - Bruce Riser - CCN3 peptides and analogs thereof for therapeutic use 
• US8133860 - 3/13/2012 - Raul Gazmuri - Facilitation of resuscitation from cardiac arrest by erythropoietin
• US8105257 - 1/31/2012 - Erin Klein, et al. - Extremity stress attenuation modality with resistance-mechanism engaging member
• US8067366 - 11/29/2011 - Raul Gazmuri - Facilitation of resuscitation from cardiac arrest by erythropoietin
• US7956037 - 6/7/2011 - Darryl Peterson - Cytoprotective therapeutic agents for the prevention of reperfusion injury following ischemic stroke 
• US7780949 - 8/24/2010 - Bruce Riser - Regulation of CCN2 by CCN3 and its therapeutic and diagnostic potential in fibrosis, sclerosis and other diseases
• US7261887 - 8/28/2007 - Kwang-Poo Chang, Sujoy Dutta. - Leishmania as carriers for the delivery of proteins and peptides 
• US7238347 - 7/3/2007 - Kwang-Poo Chang, Sujoy Dutta. - Suicidal mutant Leishmania vaccine 

Pending Patents

• 17/472,887 - 9/13/2021 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
• 17/472,046 - 9/10/2021 - Michelle Hastings - Antisense Compounds Targeting Genes Associated with Cystic Fibrosis
• 16/977,649 - 9/2/2020 - Michelle Hastings, et al. - Compounds and Methods for the Modulation of Amyloid Beta Precursor Protein
• 16/888576 - 5/29/2020 - Kwang Poo Chang - Immunotherapy of Solid Tumors by Vaccination with Transgenicleishmania Expressing Cancer Vaccines
• 16/536,981 - 8/9/2019 - Michelle Hastings, et al. - Antisense Compounds Targeted to CLN3 and Uses Thereof
• 16/414951 - 11/28/2019 - Joanna Dabrowska - System and Method for Determining a Discrimination Index for Fear-Potentiated Startle